News & Updates
Filter by Specialty:
SGLT2i better than DDP4i at preventing heart failure hospitalization, death in T2DM
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) reduce hospitalization for heart failure (hHF) and all-cause death in type 2 diabetes mellitus (T2DM) patients without a history of cardiovascular disease, reports a new study.
SGLT2i better than DDP4i at preventing heart failure hospitalization, death in T2DM
29 Mar 2022
Empagliflozin lowers mortality, cardiorenal events even in COPD presence
Among patients with type 2 diabetes mellitus and cardiovascular disease, those with concomitant chronic obstructive pulmonary disease (COPD) are at higher risk of mortality and adverse cardiorenal outcomes, including heart failure, according to post hoc analyses of the EMPA-REG OUTCOME trial. However, these outcomes can be prevented with empagliflozin treatment, regardless of the presence of COPD.
Empagliflozin lowers mortality, cardiorenal events even in COPD presence
28 Mar 2022
Healthy lifestyle lowers T2D hazard in genetically at-risk individuals
A genetic predisposition to low birth weight and childhood obesity contributes to an increased risk of adult type 2 diabetes (T2D), suggests a study. These risks can be modified by adherence to a healthy lifestyle in adulthood, particularly among those at high genetic risk of childhood obesity.
Healthy lifestyle lowers T2D hazard in genetically at-risk individuals
25 Mar 2022
HDL3 cholesterol tied to primary open-angle glaucoma
A causal and specific association exists between high-density lipoprotein (HDL) 3 cholesterol and primary open-angle glaucoma (POAG), suggests a cross-sectional study, noting that dysregulation of cholesterol transport may contribute to the pathogenesis of POAG.
HDL3 cholesterol tied to primary open-angle glaucoma
18 Mar 2022
Over-the-counter nutritional supplement may help avert gestational diabetes
Myo-inositol, a nutritional supplement that is present in fruits and fibre-rich foods, shows promise in the prevention of gestational diabetes, as reported in a study.
Over-the-counter nutritional supplement may help avert gestational diabetes
18 Mar 2022
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.
Glycaemic control not a risk factor for cerebral small vessel disease in T1D
16 Mar 2022
Early menopause tied to increased dementia risk
Individuals who experience menopause before age 50 years may be at an elevated risk of developing dementia, according to results of a UK study presented at the EPI Lifestyle Scientific Sessions 2022.